Privium Fund Management (UK)’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-61,284
Closed -$435K 60
2022
Q2
$435K Buy
+61,284
New +$435K 0.49% 61